NBTX Stock Analysis: Buy, Sell, or Hold?
NBTX - Nanobiotix S.A. American Depositary Shares
$35.20
-1.56 (-4.24%)
▼
5d:
-13.09%
30d:
+12.97%
90d:
-2.03%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NBTX is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NBTX is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $35.20, which is considered slightly low relative to its 30-day fair value range of $34.65 to $48.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 281.4) compared to its historical average (172.3). At these levels, the market is pricing in 17.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NBTX is in a strong uptrend. The price is currently testing key support at $34.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.35 (+17.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBTX is in a strong uptrend. The price is currently testing key support at $34.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.35 (+17.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$34.65 -
$48.12
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading below Wall St target ($41.35)
- NEUTRAL: Trading at premium valuation - market expects 17.8% growth which is achievable
- WARNING: Recommendation downgraded due to -13.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$34.65 -
$48.12
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$34.55
Resistance Level
$45.25
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
281.37
Wall Street Target
$41.35
(+17.5%)
Revenue Growth (YoY)
186.8%
Profit Margin
-73.5%
Valuation Premium vs History
+17.8% premium
PE vs Historical
281.4 vs 172.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+17.8%
(market-implied from PE analysis)
1-Year Target
$41.47
(+18%)
2-Year Target
$48.85
(+39%)
3-Year Target
$57.54
(+64%)
3-Yr Target (if PE normalizes)
(PE: 281→172)
PE COMPRESSION
$35.24
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 281.4, Growth: 72.6%)
$118.80
(+238%)
Base:
(SPY PE: 21.9, Growth: 72.6%)
$9.25
(-74%)
Bear:
(PE: 18.6, Growth: 72.6%)
$7.86
(-78%)
Share & Embed Analysis
Last updated: June 03, 2026 5:35 PM ET
Data refreshes hourly during market hours. Next update: 6:35 PM
Data refreshes hourly during market hours. Next update: 6:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 55 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$183 | 62 BUY |
